| Literature DB >> 27838393 |
Francesco Calì1, Valeria Chiavetta2, Giuseppa Ruggeri2, Maria Piccione3, Angelo Selicorni4, Daniela Palazzo3, Maria Bonsignore5, Anna Cereda6, Maurizio Elia7, Pinella Failla7, Maria Grazia Figura7, Agata Fiumara8, Silvia Maitz9, Giuseppa Maria Luana Mandarà10, Teresa Mattina8, Alda Ragalmuto2, Corrado Romano7, Martino Ruggieri8, Roberto Salluzzo2, Antonino Saporoso5, Carmelo Schepis7, Giovanni Sorge8, Maria Spanò5, Gaetano Tortorella5, Valentino Romano11.
Abstract
Neurofibromatosis type 1 (NF1) is caused by mutations of the NF1 gene and is one of the most common human autosomal dominant disorders. The patient shows different signs on the skin and other organs from early childhood. The best known are six or more café au lait spots, axillary or inguinal freckling, increased risk of developing benign nerve sheath tumours and plexiform neurofibromas. Mutation detection is complex, due to the large gene size, the large variety of mutations and the presence of pseudogenes. Using Ion Torrent PGM™ Platform, 73 mutations were identified in 79 NF1 Italian patients, 51% of which turned out to be novel mutations. Pathogenic status of each variant was classified using "American College of Medical Genetics and Genomics" guidelines criteria, thus enabling the classification of 96% of the variants identified as being pathogenic. The use of Next Generation Sequencing has proven to be effective as for costs, and time for analysis, and it allowed us to identify a patient with NF1 mosaicism. Furthermore, we designed a new approach aimed to quantify the mosaicism percentage using electropherogram of capillary electrophoresis performed on Sanger method.Entities:
Keywords: Legius's syndrome; Mosaicism; Neurofibromatosis type 1; Next generation sequencing
Mesh:
Substances:
Year: 2016 PMID: 27838393 DOI: 10.1016/j.ejmg.2016.11.001
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708